Loading...
Loading...
Baird Medical Investment Holdings Ltd
Baird Medical Investment Holdings Ltd. Spoken Alpha tracks BDMD's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BDMD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 90% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BDMD.
curl https://api.spokenalpha.com/v1/companies/BDMD| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.07 | $0.78 | +37.4% | -5.7% | -8.5% |
| Q4 FY2026 | $1.05 | $0.74 | +42.5% | -5.0% | -6.2% |
| Q3 FY2026 | $1.29 | $0.99 | +30.5% | +1.5% | +1.2% |
| Q2 FY2026 | $1.11 | $0.83 | +33.2% | -5.0% | -4.0% |
| Q1 FY2025 | $1.27 | $0.94 | +34.6% | -0.1% | -1.6% |
| Q4 FY2025 | $1.10 | $0.82 | +34.3% | -6.7% | -7.3% |
| Q3 FY2025 | $1.33 | $1.00 | +33.1% | -4.9% | -6.1% |
| Q2 FY2025 | $1.26 | $0.93 | +35.7% | -5.1% | -5.6% |
| Q1 FY2024 | $1.14 | $0.87 | +31.4% | -4.0% | -1.7% |
| Q4 FY2024 | $1.35 | $0.98 | +37.3% | 0.0% | -1.3% |